'Colorectal liver metastases' 'Liver Neoplasms / Surgery' 'Infusion pumps' 'Infusions, intra-arterial' Colon cancer with liver metastases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Unresectable CRLM (as assessed by liver expert panel) • Resectable primary tumour without indication for neoadjuvant treatment • No previous systemic therapy for colorectal cancer • No extrahepatic metastases • Suitable arterial anatomy for pump placement • Written informed consent
Exclusion criteria
Exclusion criteria: • DPD-deficiency • MMR-deficiency
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival (OS). | — |
Secondary
| Measure | Time frame |
|---|---|
| progression-free survival (PFS), conversion-to-resection rate, R0/R1 resection rate, hepatic progression-free survival (hPFS), radiological response, pathological response, complication rates for pump placement, surgery for the primary tumour and conversion surgery, toxicity of HAIP and systemic therapy, quality of life and cost effectiveness. | — |
Countries
Netherlands
Contacts
Antoni van Leeuwenhoek (AVL)